Blar i Department of Clinical Medicine på forfatter "Bakke, Per S."

Viser treff 1-2 av 2

    • Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort 

      Le, Lan Ai Kieu; Johannessen, Ane; Hardie, Jon Andrew; Johansen, Odd Erik; Gulsvik, Amund; Vikse, Bjørn Egil; Bakke, Per S. (Peer reviewed; Journal article, 2019-07-23)
      Rationale: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 is based on an ABCD assessment tool of symptoms and exacerbation history and grade 1–4 of airflow limitation severity, facilitating ...

    • Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study 

      Reinke, Stacey N.; Naz, Shama; Chaleckis, Romanas; Gallart-Ayala, Hector; Kolmert, Johan; Kermani, Nazanin Z.; Tiotiu, Angelica; Broadhurst, David I.; Lundqvist, Anders; Olsson, Henric; Ström, Marika; Wheelock, Åsa M.; Gómez, Cristina; Ericsson, Magnus; Sousa, Ana R.; Riley, John H.; Bates, Stewart; Scholfield, James; Loza, Matthew; Baribaud, Frédéric; Bakke, Per S.; Caruso, Massimo; Chanez, Pascal; Fowler, Stephen J.; Geiser, Thomas; Howarth, Peter; Horváth, Ildikó; Krug, Norbert; Montuschi, Paolo; Behndig, Annelie; Singer, Florian; Musial, Jacek; Shaw, Dominick E.; Dahlén, Barbro; Hu, Sile; Lasky-Su, Jessica; Sterk, Peter J.; Chung, Kian Fan; Djukanovic, Ratko; Dahlén, Sven-Erik; Adcock, Ian M.; Wheelock, Craig E. (Journal article; Peer reviewed, 2022)
      Introduction Asthma is a heterogeneous disease with poorly defined phenotypes. Patients with severe asthma often receive multiple treatments including oral corticosteroids (OCS). Treatment may modify the observed metabotype, ...